Gilead Sciences Battles Rising Threat of Drug Counterfeiting

Gilead Sciences Inc (NASDAQ: GILD) faces a severe threat from the rise in drug counterfeiting, a global issue highlighted by the World Health Organization's staggering estimate of up to $431 billion in 

Related Keywords

Geoffrey Potter , Johnson , Gilead Sciences Inc , Security Institute , Safe Chain Solutions , World Health Organization , Pharmaceutical Security , Propharma Distribution ,